Gary J. Martinelli
Pfizer
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Gary J. Martinelli.
Journal of Medicinal Chemistry | 2010
Kevin Daniel Freeman-Cook; Christopher Autry; Gary Borzillo; Deborah Gordon; Elsa G. Barbacci-Tobin; Vincent Bernardo; David Briere; Tracey Clark; Matthew Corbett; John Jakubczak; Shefali Kakar; Elizabeth Knauth; Blaise Lippa; Michael Joseph Luzzio; Mahmoud N. Mansour; Gary J. Martinelli; Matthew A. Marx; Kendra Louise Nelson; Jayvardhan Pandit; Francis Rajamohan; Shaughnessy Robinson; Chakrapani Subramanyam; Liuqing Wei; Martin James Wythes; Joel Morris
This paper describes the design and synthesis of novel, ATP-competitive Akt inhibitors from an elaborated 3-aminopyrrolidine scaffold. Key findings include the discovery of an initial lead that was modestly selective and medicinal chemistry optimization of that lead to provide more selective analogues. Analysis of the data suggested that highly lipophilic analogues would likely suffer from poor overall properties. Central to the discussion is the concept of optimization of lipophilic efficiency and the ability to balance overall druglike propeties with the careful control of lipophilicity in the lead series. Discovery of the nonracemic amide series and subsequent modification produced an advanced analogue that performed well in advanced preclinical assays, including xenograft tumor growth inhibition studies, and this analogue was nominated for clinical development.
Tetrahedron Letters | 1992
James R. Hauske; Peter Hans Dorff; Susan Julin; Gary J. Martinelli; Jacqueline C. Bussolari
Abstract Exposure of chiral amino aldehydes ( 1 ) to dimethyl diazophosphonate ( 4 ) affords propargylic amines ( 2 ) of high optical purity. Chain extension of these intermediates is readily accomplished via hydrozirconation of the acetylene moiety and subsequent Ni(II) catalyzed Michael addition to a variety of Michael acceptors.
Bioorganic & Medicinal Chemistry Letters | 2000
Lawrence A. Reiter; Gary J. Martinelli; Lisa A Reeves; Peter G. Mitchell
Substrate-like difluoroketones have been prepared as potential inhibitors of MMP-13. Weak inhibition was seen with the key target 2. This and the more potent activity of intermediate 7b illustrates that hydrated ketones can be used to inhibit MMP-13 and perhaps other members of this class of enzymes.
Bioorganic & Medicinal Chemistry Letters | 2010
Michael Scott Visser; Kevin Daniel Freeman-Cook; Steven J. Brickner; Katherine E. Brighty; Phuong T. Le; Sarah K. Wade; Rhonda Monahan; Gary J. Martinelli; Kyle T. Blair; Dianna E. Moore
Novel hygromycin A derivatives bearing a variety of functionalized aminocyclitol moieties have been synthesized in an effort to increase the antibacterial activity and drug-like properties of this class of agents. A systematic study of the effect of alkylation and removal of the hydroxyls of the aminocyclitol directed us to a series of alkylated aminocyclitol derivatives with improved gram-positive activity.
Bioorganic & Medicinal Chemistry Letters | 2004
Lawrence A. Reiter; Ralph P. Robinson; Kim F. McClure; Christopher S. Jones; Matthew R. Reese; Peter G. Mitchell; Ivan G. Otterness; Marcia L. Bliven; Jennifer Liras; Santo R. Cortina; Kathleen M. Donahue; James D. Eskra; Richard J. Griffiths; Mary E. Lame; Arturo Lopez-Anaya; Gary J. Martinelli; Shunda M. McGahee; Sue A. Yocum; Lori L. Lopresti-Morrow; Lisa M. Tobiassen; Marcie L. Vaughn-Bowser
Bioorganic & Medicinal Chemistry Letters | 2006
Lawrence A. Reiter; Kevin Daniel Freeman-Cook; Christopher S. Jones; Gary J. Martinelli; Amy S. Antipas; Martin A. Berliner; Kaushik Datta; James T. Downs; James D. Eskra; Michael D. Forman; Elaine M. Greer; Roberto E. Guzman; Joel R. Hardink; Fouad Janat; Nandell F. Keene; Ellen R. Laird; Jennifer Liras; Lori L. Lopresti-Morrow; Peter G. Mitchell; Jayvardhan Pandit; Donald G. Robertson; Diana Sperger; Marcie L. Vaughn-Bowser; Darra M. Waller; Sue A. Yocum
Bioorganic & Medicinal Chemistry Letters | 2003
Lawrence A. Reiter; Peter G. Mitchell; Gary J. Martinelli; Lori L. Lopresti-Morrow; Sue A. Yocum; James D. Eskra
Bioorganic & Medicinal Chemistry Letters | 1999
Lawrence A. Reiter; James P. Rizzi; Jayvardan Pandit; Michael J. Lasut; Shunda M. McGahee; Vinod D. Parikh; James F. Blake; Dennis E. Danley; Ellen R. Laird; Arturo Lopez-Anaya; Lori L. Lopresti-Morrow; Mahmoud N. Mansour; Gary J. Martinelli; Peter G. Mitchell; Brian S. Owens; Thomas A. Pauly; Lisa M. Reeves; Gayle K. Schulte; Sue A. Yocum
Bioorganic & Medicinal Chemistry Letters | 2007
Kevin Daniel Freeman-Cook; Lawrence A. Reiter; Mark C. Noe; Amy S. Antipas; Dennis E. Danley; Kaushik Datta; James T. Downs; Shane Allen Eisenbeis; James D. Eskra; David J. Garmene; Elaine M. Greer; Richard J. Griffiths; Roberto E. Guzman; Joel R. Hardink; Fouad Janat; Christopher S. Jones; Gary J. Martinelli; Peter G. Mitchell; Ellen R. Laird; Jennifer Liras; Lori L. Lopresti-Morrow; Jayvardhan Pandit; Usa Reilly; Donald G. Robertson; Marcie L. Vaughn-Bowser; Lilli A. Wolf-Gouviea; Sue A. Yocum
Bioorganic & Medicinal Chemistry Letters | 1998
Lawrence A. Reiter; Kevin Koch; Anthony D. Piscopio; Henry J. Showell; Robbin Alpert; Michael S. Biggers; Robert J. Chambers; Maryrose J. Conklyn; Kelvin Cooper; Santo R. Cortina; Joseph DiBrino; Beryl W. Dominy; Cathy A. Farrell; Gary P. Hingorani; Gary J. Martinelli; Mukesh Ramchandani; Kathyrn F. Wright